Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Post-treatment control of HIV infection

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [2]
  1. The Pennsylvania State Univ., University Park, PA (United States); Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Antiretroviral therapy (ART) for HIV is not a cure. However, recent studies suggest that ART, initiated early during primary infection, may induce post-treatment control (PTC) of HIV infection with HIV RNA maintained at <50 copies per mL. We investigate the hypothesis that ART initiated early during primary infection permits PTC by limiting the size of the latent reservoir, which, if small enough at treatment termination, may allow the adaptive immune response to prevent viral rebound (VR) and control infection. We use a mathematical model of within host HIV dynamics to capture interactions among target cells, productively infected cells, latently infected cells, virus, and cytotoxic T lymphocytes (CTLs). Analysis of our model reveals a range in CTL response strengths where a patient may show either VR or PTC, depending on the size of the latent reservoir at treatment termination. Below this range, patients will always rebound, whereas above this range, patients are predicted to behave like elite controllers. As a result, using data on latent reservoir sizes in patients treated during primary infection, we also predict population-level VR times for non-controllers consistent with observations.
Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1233166
Report Number(s):
LA--UR-14-27986
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Journal Name: Proceedings of the National Academy of Sciences of the United States of America Journal Issue: 17 Vol. 112; ISSN 0027-8424
Publisher:
National Academy of Sciences, Washington, DC (United States)Copyright Statement
Country of Publication:
United States
Language:
English

References (73)

A Stochastic Model for Early HIV-1 Population Dynamics journal December 1998
Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses? journal January 2010
Immune impairment thresholds in HIV infection journal April 2009
Modeling HIV persistence, the latent reservoir, and viral blips journal September 2009
Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips journal January 2009
Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay journal January 2004
Erratum: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy journal August 2012
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning journal August 2013
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant journal November 2013
Stochastic variability in HIV affects viral eradication journal September 2014
HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication journal October 2005
Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV journal January 2009
Emerging strategies to deplete the HIV reservoir journal January 2014
The race between initial T–helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set–point journal July 2003
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time journal March 1996
Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection journal March 2012
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies journal February 2013
Modeling Plasma Virus Concentration during Primary HIV Infection journal April 2000
The Dual Role of CD4 T Helper Cells in the Infection Dynamics of HIV and Their Importance for Vaccination journal February 2002
Estimation and Prediction With HIV-Treatment Interruption Data journal January 2007
Revisiting Immune Exhaustion During HIV Infection journal December 2010
Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay journal January 2004
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure journal October 2013
Quantifying T lymphocyte turnover journal June 2013
Reactivation of latent HIV by histone deacetylase inhibitors journal June 2013
Elucidating the elite: mechanisms of control in HIV-1 infection journal December 2009
Pharmaceutical approaches to eradication of persistent HIV infection journal February 2009
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection journal May 1997
Decay characteristics of HIV-1-infected compartments during combination therapy journal May 1997
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy journal January 2000
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy journal July 2012
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys journal July 2014
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation journal June 2009
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells journal May 2003
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants journal November 2008
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant journal November 2013
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype journal April 2007
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection journal May 2008
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection journal May 2012
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 journal August 2014
Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection journal July 1998
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
  • Okulicz, Jason F.; Marconi, Vincent C.; Landrum, Michael L.
  • The Journal of Infectious Diseases, Vol. 200, Issue 11 https://doi.org/10.1086/646609
journal December 2009
Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation journal March 2013
Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts journal January 2013
Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection journal January 2000
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection journal January 2003
Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV journal January 2009
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication journal January 2010
Emerging strategies to deplete the HIV reservoir journal January 2014
Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals journal June 2013
The Challenge of Finding a Cure for HIV Infection journal March 2009
Vaccination Alters the Balance between Protective Immunity, Exhaustion, Escape, and Death in Chronic Infections journal March 2011
Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells journal June 2006
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia journal October 2008
Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation journal April 2011
A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo journal April 2003
Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection journal August 2004
Stochastic Analysis of Pre- and Postexposure Prophylaxis against HIV Infection journal January 2013
Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans journal September 2013
Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy journal January 2011
Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy journal January 2006
Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy journal October 2009
Treatment-Mediated Alterations in HIV Fitness Preserve CD4+ T Cell Counts but Have Minimal Effects on Viral Load journal November 2010
Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions journal February 2011
A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients journal April 2011
Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy journal October 2013
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation journal June 2009
A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model journal June 2012
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study journal March 2013
Therapeutic and prophylactic DNA vaccines for HIV-1 journal January 2013
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy journal January 2012
PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention journal May 2009
Dendritic cell based vaccines for HIV infection: The way ahead journal November 2013

Cited By (38)

Towards multiscale modeling of the CD8 + T cell response to viral infections journal February 2019
Latent HIV dynamics and implications for sustained viral suppression in the absence of antiretroviral therapy journal April 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection journal June 2018
Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics journal April 2019
Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents journal January 2016
Windows of opportunity for Ebola virus infection treatment and vaccination posted_content April 2017
A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections posted_content February 2019
Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells journal May 2016
Analysis of an HIV model with post-treatment control journal January 2020
Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents journal February 2018
Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers journal July 2019
Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV journal April 2016
Modeling Kick-Kill Strategies toward HIV Cure journal August 2017
Immunological Paradigms, Mechanisms, and Models: Conceptual Understanding Is a Prerequisite to Effective Modeling journal November 2019
Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling journal July 2018
Monotonic and nonmonotonic immune responses in viral infection systems journal January 2022
Thresholds and bistability in HIV infection models with oxidative stress preprint January 2018
Life cycle synchronization is a viral drug resistance mechanism text January 2018
Within-host and synaptic transmissions: contributions to the spread of HIV infection: A. R. M. CARVALHO AND C. M. A. PINTO journal June 2016
Stochastic Dynamics of the Latently Infected Cell Reservoir During HIV Infection journal October 2018
Modeling HIV Dynamics Under Combination Therapy with Inducers and Antibodies journal June 2019
Functional cure of HIV: the scale of the challenge journal November 2018
Why and where an HIV cure is needed and how it might be achieved journal December 2019
Probabilistic control of HIV latency and transactivation by the Tat gene circuit journal November 2018
A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections journal August 2019
Herpes simplex virus-2 dynamics as a probe to measure the extremely rapid and spatially localized tissue-resident T-cell response journal August 2018
Mathematical modeling of within-host Zika virus dynamics journal August 2018
Insight into treatment of HIV infection from viral dynamics models journal August 2018
Might dolutegravir be part of a functional cure for HIV? journal May 2016
From Individual Health to Community Health: Towards Multiscale Modeling of Directly Transmitted Infectious Disease Systems journal March 2019
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers journal August 2018
Dual targeting of the thioredoxin and glutathione systems in cancer and HIV journal May 2016
Life cycle synchronization is a viral drug resistance mechanism journal February 2018
HIV control: Is getting there the same as staying there? journal November 2018
CD8+ lymphocyte control of SIV infection during antiretroviral therapy journal October 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers text January 2018
Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure journal June 2018
Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV text January 2016

Similar Records

Modeling the effects of vorinostat in vivo reveals both transient and delayed HIV transcriptional activation and minimal killing of latently infected cells
Journal Article · Thu Oct 22 20:00:00 EDT 2015 · PLoS Pathogens · OSTI ID:1235937

Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
Journal Article · Tue Jul 23 20:00:00 EDT 2019 · PLoS Computational Biology (Online) · OSTI ID:1627260

Deep latency: A new insight into a functional HIV cure
Journal Article · Sun Jun 30 20:00:00 EDT 2019 · EBioMedicine · OSTI ID:1570103